World journal of surgery · 2009
Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cagol Matteo, Ruol Alberto, Castoro Carlo, Alfieri Rita, Michieletto Silvia, Ancona Ermanno
Аннотация
BACKGROUND: Chylothorax after transthoracic esophagectomy for cancer is an uncommon but potentially life-threatening postoperative complication. It has been reported that preventive thoracic duct ligation can reduce the incidence of postoperative chylothorax after esophagectomy for cancer. In this prospective series, we evaluated the results of preventive intraoperative thoracic duct mass ligation in patients who underwent transthoracic esophagectomy for cancer.
METHODS: From 2001 to 2006, 323 patients underwent transthoracic esophagectomy for cancer and duct ligation during the operation was routinely performed.
RESULTS: No intraoperative or postoperative complications directly related to the procedure were recorded. No postoperative chylothorax was observed.
CONCLUSIONS: In this series, the technique of intraoperative thoracic duct mass ligation proved to be safe and effectively prevented postoperative chylothorax in patients who underwent transthoracic esophagectomy for cancer.
METHODS: From 2001 to 2006, 323 patients underwent transthoracic esophagectomy for cancer and duct ligation during the operation was routinely performed.
RESULTS: No intraoperative or postoperative complications directly related to the procedure were recorded. No postoperative chylothorax was observed.
CONCLUSIONS: In this series, the technique of intraoperative thoracic duct mass ligation proved to be safe and effectively prevented postoperative chylothorax in patients who underwent transthoracic esophagectomy for cancer.